发明名称 |
MARKER PEPTIDES FOR DETERMINING THE OCCURRENCE OF AN INFLAMMATORY STATE IN A SUBJECT |
摘要 |
An enzyme proteolysis-resistant peptide that binds to antibodies directed against the amino acid region 1-116 of the endocan's polypeptide sequence, which peptide possesses an apparent molecular weight of 14 kDa. |
申请公布号 |
US2015168399(A1) |
申请公布日期 |
2015.06.18 |
申请号 |
US201514621427 |
申请日期 |
2015.02.13 |
申请人 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) ;Institut Pasteur De Lille |
发明人 |
DE FREITAS CAIRES Nathalie;LASSALLE Philippe;HAUW Philippe |
分类号 |
G01N33/566 |
主分类号 |
G01N33/566 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for determining the occurrence of an inflammatory state in a subject, comprising the steps of:
a) providing a sample previously collected from the said subject, b) measuring the amount value of: (i) at least one enzyme proteolysis-resistant peptide that binds to antibodies directed against the amino acid region 1-116 of the endocan polypeptide sequence of SEQ ID NO: 1, which peptide possesses an apparent molecular weight of 14 kDa, and (ii) of human endocan of SEQ ID NO: 1, in the said sample, c) determining the inflammatory state of the said subject from the ratio of the amount values of (i) the at least one enzyme proteolysis-resistant peptide measured at step b), to (ii) the human endocan measured at step b). |
地址 |
Paris FR |